MedTrace Logo

Treatment of Blepharitis With Povidone-Iodine 1%

NCT05160623 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-12-16

No results posted yet for this study

Summary

One hundred blepharitis patients will be recruited. Each patient will treat one eye once daily with 1% PVI for 30 days by scrubbing the eyelid margin with the solution. The fellow eye will serve as the control and be given the standard treatment (commercial eye wipes). Before treatment initiation, various ocular surface variables will be assessed, such as dry eye grading, subjective discomfort scales, ocular surface questionnaire, and other clinical signs. After 30 days, an identical evaluation will be performed.

Conditions

  • Anterior Blepharitis

Interventions

DRUG

Povidone-Iodine 1 % Topical Solution

Povidone-Iodine 1 % topical solution on a makeup remover pad, used to clean the lids and lashes once daily

DRUG

Eyelid cleansing wipes

EYECARE FORTE eyelid wipes (Dr. Fischer, Israel), used to clean the lids and lashes once daily

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Elishai Assayag, MD · Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05160623 on ClinicalTrials.gov